XtalPi

Q: What industry does XtalPi belong to?

XtalPi is in the industry of: Drug Stores & Pharmacies , Retail

Drug Stores & Pharmacies · China · 285 Employees

Founded in 2014, XtalPi is a biotech firm that uses artificial intelligence and computing to accelerate the development of new drugs. The firm uses algorithms to predict the crystalized form a drug will take. The data enables XtalPi to work with other pharmaceutical companies to develop new drugs and create new patents.XtalPi is located in ChinaRead More

Contact

Who is XtalPi

Headquarters

20f E Futian District, Shenzhen, China

Phone Number

(617) 717-9867

Website

www.xtalpi.com

Revenue

$62M

Industry

Drug Stores & Pharmacies

Retail

Is this data correct?

View contact profiles from XtalPi

XtalPi Org Chart

Phone

Sarah Trice

Chief Operating Officer, U.S...

Phone

Ian Lee

Deputy Chief Financial Offic...

Phone

View Email Formats for XtalPi

XtalPi Company Metrics

Company Insights

Employee Growth Rate

Funding

Funding DateAug 16, 2021

RoundSeries D

Amount$400M

InvestorsHOPU Investment Management Co., OrbiMed Healthcare Fund Management

Funding DateMar 22, 2021

RoundSeries B

Amount$61M

InvestorsBGF, Tencent, China Life Healthcare Fund, Yael Capital, Google Ventures, Sequoia China

Funding DateSep 28, 2020

RoundSeries C

Amount$318.8M

InvestorsThe Morningside Group, PICC Capital, SoftBank Vision Fund 2

$784.8M

Total Funding Amount

$400M

Most Recent Funding Amount

Number of Funding Rounds

XtalPi News & Media

XtalPi Names New COO for U.S. Operations, Bringing Its Autonomous Labs to Boston in Continued Global Expansion
SHENZHEN, China, Jan. 11, 2023 /PRNewswire/ -- XtalPi, Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced that Dr. Sarah Trice has joined the company as chief operating officer of U.S. operations. Dr. Trice will report...
Jan 11, 2023
www.prnewswire.com
XtalPi and EDDC collaborate in AI-empowered drug discovery program for Non-Small Cell Lung Cancer
XtalPi joins hands with Singapore's national platform for drug discovery and development to discover more effective treatment options for cancer patients worldwide SHENZHEN, China and SINGAPORE, Dec. 19, 2022 /PRNewswire/ -- XtalPi, a pioneering pharmaceutical technology company powered...
Dec 20, 2022
www.prnewswire.com
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation
AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide SHENZHEN & HONG KONG, China, Nov. 24, 2022 /PRNewswire/ -- XtalPi announced today that they are embarking on a strategic collaboration...
Nov 25, 2022
www.prnewswire.com
XtalPi Announces Research Collaboration with Janssen
SHENZHEN, China, Oct. 27, 2022 /PRNewswire/ -- XtalPi, Inc., a privately-held solution provider accelerating biopharmaceutical research via its integrated technology platform, announced a research collaboration with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of...
Oct 27, 2022
www.prnewswire.com
Meta Pharmaceuticals Raises 15M USD in Funding
Meta Pharmaceuticals, a Shenzen, China-based immunometabolism-based small-molecule drug discovery company, raised $15M in funding. The round was led by Forcefield Ventures, XtalPi Inc., IMO Ventures, and Tiantu Capital. The company intends to use the funds to accelerate its three candidates toward clinical trials and further expand its proprietary platform to cover more disease areas as it […] The post Meta Pharmaceuticals Raises 15M USD in Funding appeared first on FinSMEs.
Jun 13, 2022
www.finsmes.com